2022
DOI: 10.1111/his.14641
|View full text |Cite
|
Sign up to set email alerts
|

The pathological and molecular genetic landscape of the hereditary renal cancer predisposition syndromes

Abstract: It is estimated that 5–8% of renal tumours are hereditary in nature, with many inherited as autosomal‐dominant. These tumours carry a unique spectrum of pathological and molecular alterations, the knowledge of which has expanded in recent years. Due to this knowledge, many advances in the treatment of these tumours have been achieved. In this review, we summarize the current understanding of the genetic renal neoplasia syndromes, clinical and pathological presentations, molecular pathogenesis, advances in ther… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 134 publications
(262 reference statements)
0
1
0
Order By: Relevance
“…These tumors carry a unique spectrum of pathologic and molecular alterations, the knowledge of which has been expanding in recent years. Indebted to this knowledge, many advances in the treatment of these tumors have been achieved ( 5 ). There are numerous etiologies for hereditary kidney cancer, including von Hippel-Lindau (VHL) disease, hereditary leiomyomatosis and renal cell carcinoma (HLRCC), hereditary papillary renal cell carcinoma type 1 (HPRCC1), Tuberous Sclerosis Complex 1/2 (TSC1/2), Birt-Hogg-Dube disease (BHD), and other related genetic disorders ( 6 ).…”
Section: Introductionmentioning
confidence: 99%
“…These tumors carry a unique spectrum of pathologic and molecular alterations, the knowledge of which has been expanding in recent years. Indebted to this knowledge, many advances in the treatment of these tumors have been achieved ( 5 ). There are numerous etiologies for hereditary kidney cancer, including von Hippel-Lindau (VHL) disease, hereditary leiomyomatosis and renal cell carcinoma (HLRCC), hereditary papillary renal cell carcinoma type 1 (HPRCC1), Tuberous Sclerosis Complex 1/2 (TSC1/2), Birt-Hogg-Dube disease (BHD), and other related genetic disorders ( 6 ).…”
Section: Introductionmentioning
confidence: 99%